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Abstract The multifunctional regulator nuclear factor
erythroid 2-related factor (Nrf2) is considered not only as a
cytoprotective factor regulating the expression of genes
coding for anti-oxidant, anti-inflammatory and detoxifying
proteins, but it is also a powerful modulator of species
longevity. The vertebrate Nrf2 belongs to Cap ‘n’ Collar
(Cnc) bZIP family of transcription factors and shares a high
homology with SKN-1 from Caenorhabditis elegans or
CncC found in Drosophila melanogaster. The major
characteristics of Nrf2 are to some extent mimicked by
Nrf2-dependent genes and their proteins including heme
oxygenase-1 (HO-1), which besides removing toxic heme,
produces biliverdin, iron ions and carbon monoxide. HO-1
and their products exert beneficial effects through the
protection against oxidative injury, regulation of apoptosis,
modulation of inflammation as well as contribution to
angiogenesis. On the other hand, the disturbances in the
proper HO-1 level are associated with the pathogenesis of
some age-dependent disorders, including neurodegenera-
tion, cancer or macular degeneration. This review
summarizes our knowledge about Nrf2 and HO-1 across
different phyla suggesting their conservative role as stress-
protective and anti-aging factors.
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Adaptive response to oxidative stress through Nrf2
and its target genes
Living organisms are frequently exposed to oxidative stress
and toxic insults, like radiation, UV light, air pollution,
toxins and others. Oxidative stress generated during such
stressful conditions may damage DNA and proteins, and as
a consequence the cellular processes are disturbed. Special
cellular machinery should be activated to fight against
increased reactive oxygen species (ROS) level to protect
from oxidative injury. Single cells and organisms may
adapt to harmful oxidative stress conditions, through stress-
activated factors.
The nuclear factor erythroid 2-related factor 2 (Nrf2;
encoded by Nfe2l2 gene) is a transcription factor responsi-
ble for the regulation of cellular redox balance and
protective antioxidant and phase II detoxification responses
in mammals [1, 2]. The discovery of the antioxidant
response element (ARE) have led to the conclusion that the
battery of genes, including glutamate-cysteine ligase
(GCL), thioredoxin reductase 1 (Txnrd1), NAD(P)H-qui-
none oxidoreductase 1 (NQO1) and heme oxygenase-1
(HMOX1) is regulated through Nrf2 binding to this con-
sensus binding sequence [3]. This activates cascade of
events which, in the end, affects oxidative status of the cells
and provides robust protection against oxidative challenge.
Nrf2 is a master eukaryotic redox-active factor and
belongs to Cap ‘n’ Collar (Cnc)-bZIP (basic leucine zipper)
family of transcription factors. Apart from Nrf2, also other
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NF-E2 p45-related factors 1 and 3 (Nrf1 and Nrf3) as well
as transcriptional repressors Bach1 and Bach2 are the
members of the family (reviewed in [4]). Nrf2 consists of
six functional Neh domains (Neh1-Neh6), from which, the
amino-terminal Neh2 domain controls binding Keap1—the
inhibitor protein Kelch-like ECH-associated protein 1, that
is responsible for the cytosolic sequestration of Nrf2 under
physiological conditions (Fig. 2a). Keap1 is a cysteine-rich
protein, known to be anchored to actin cytoskeleton [5],
serving as an adaptor protein for the Cul3-dependent E3
ubiquitin ligase complex. Under normal conditions, Keap1
promotes ubiquitination and eventual degradation of Nrf2.
This is a relatively rapid event, with Nrf2 exhibiting a short
half-life of approximately 20 min [6]. On the other hand,
under the stressful conditions, in which electrophiles and
oxidants switch on Nrf2-dependent cellular defense
mechanism, Nrf2 is released from Keap1 and translocates
to the nucleus where it binds to conserved ARE sequence
(reviewed in [7]). Keap1, as a thiol-rich protein, possesses
at least 27 reactive cysteines that can be modified by
electrophiles what leads to Keap1 inactivation and Nrf2
stabilization [8]. Nrf2 stabilization and increase in its half-
life even to 200 min [9] allows nuclear translocation and
activation of transcription of cytoprotective genes (Fig. 1).
From abovementioned cysteines, two residues, Cys273 and
Cys288, are crucial for Keap1 to control Nrf2 under both
basal and stress conditions, whereas Cys151 is important
for Keap1 activity predominantly in stressful conditions
(reviewed in [10]).
As mentioned above, Neh2 domain identified in Nrf2 at
the N-terminal end, is responsible for Keap1 binding. This
interaction requires two key amino acid sequences within
Neh2: ETGE and DLG (Fig. 2a). The other functional
domains in Nrf2 play an important role in the regulation of
transcriptional activity or its degradation. Neh4 and Neh5
domains are capable to interact with CREB-binding protein,
CBP, enhancing the transcriptional activity of Nrf2. Neh6 is
rich in serine residues, and this domain together with Neh2
plays a crucial role in Nrf2 degradation. The key Neh1
domain includes CNC-bZip motif responsible for DNA
binding and dimerization with small Maf proteins. The next
after Neh1, is the C-terminal Neh3 domain [11–14].
Similarly, in Keap1 protein-specific domains are iden-
tified. After the N-terminal region (NTR), the BTB domain
Fig. 1 Schematic representation of the Nrf2-Keap1 pathway. Under
normal conditions, Nrf2 is sequestered in cytoplasm by Keap1. In
stressful conditions the modification of –SH groups in Keap1 or
phosphorylation of Nrf2 facilitate the dissociation of Nrf2 from
Keap1 as well as translocation of Nrf2 into the nucleus. After binding
Maf proteins, Nrf2 activates antioxidant response element (ARE) and
increases transcription of Nrf2-regulated genes (e.g., HO-1, GST,
NQO-1)
cFig. 2 Complexity of CNC transcription factors and Keap1 regulator.
CNC family of transcription factors share a high homology between
D. melanogaster, C. elegans and Homo sapiens. From three Nrf
factors found in vertebrates, the detailed domain structure of Nrf2 is
shown. In C. elegans, three isoforms of SKN-1 factor possessing CNC
domain responsible for DNA binding have been identified. In D.
melanogaster CncA, CncB and CncC have distinct N-terminal end,
but share very homologous C-terminus harboring the bZIP (a).
Mammalian Keap1 consists of several domains which contain crucial
cysteine residues. In zebrafish, two types of Keap1 with high
homology to mammalian Keap1 are identified (similarity in amino
acid sequences between zebrafish and mouse Keap1 shown in
percentage). Keap1a and Keap1b, differ in the presence of essential
Cys273 and Cys288, whereas dKeap1 in Drosophila lacks other
cysteines but possess Cys273 and Cys288. In nematode, the function
of negative regulator of SKN-1 is played by WDR-23 (b)
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(named after the Drosophila proteins Broad complex,
Tramtrack, and Bric-a-brac, in which it was first identified),
required for the formation of Keap1 homodimers and
recruitment of Cullin-3 (Cul3) is present. The intervening
region (IVR) also contributes to interaction with Cul3,
whereas Nrf2 binding is controlled by the Kelch-repeat
domain consisting of six repeats with double-glycine
repeats (DGR)—key structural features of the Kelch
domains (Fig. 2b) (reviewed in [10]).
Evolutionary conservation of Cnc transcription
factors
Nrf2-Keap1 system has been mostly studied in mammalian
cells; however, a growing body of evidence suggest that
similar pathways may play an important role in the pro-
tection against oxidative stress in other organisms. In 2002,
Kobayashi et al. have identified and characterized the
orthologues of Nrf2 and Keap1 in the zebrafish Danio rerio
as the primary regulatory system of cytoprotective enzyme
genes [15]. After treatment of the zebrafish larvae with
tert-butylhydroquinone (tBHQ), the induction of cytopro-
tective and detoxifying genes like, gstp1, nqo1 and cgcsh
was observed, similarly to mammalian cells. Comparing
Nrf2 of zebrafish and mouse, Kobayashi et al. found the
sequence identity between the Neh1 and Neh2 domains of
about 70 % [15]. In 2013, Williams et al. have demon-
strated that the zebrafish expresses six nrf genes (nfe2,
nrf1a, nrf1b, nrf2a, nrf2b, and nrf3). In this species, due to
the whole genome duplication such multiplied copies
(paralogues) that are co-orthologues of many single copy
human genes are present [16]. Like the mammalian Nrf2,
also in zebrafish this protein interacts with Keap1. Inter-
estingly, two types of Keap1, Keap1a and Keap1b were
identified by Li and coworkers [17]. It was shown that
similarly to the mechanism observed in mammals, inhibi-
tion of Nrf2 by Keap1 is dependent on the interaction
between Neh2 and Kelch domains as the specific mutation
of the ETGE motif in Neh2 domain in zebrafish Nrf2 led to
its escape from Keap1-mediated sequestration and nuclear
localization [15, 17]. However, Keap1a and Keap1b lack a
cysteine residue corresponding to mammalian Cys273 and
Cys288, respectively [17]. Nevertheless, the presence of
either Cys273 or Cys288 is sufficient for fish Keap1
molecules to exert full activity (Fig. 2b).
Similar factor to the mammalian Nrf2, responsible for
oxidant signaling, was also identified in nematodes
(Fig. 2). In 2003, An and Blackwell have shown that SKN-
1 (skinhead-1) transcription factor is an orthologue of Nrf2
[18]. They and others have found that similarly to Nrf2,
under normal conditions SKN-1 is sequestered in cyto-
plasm, but it translocates to the nucleus in response to
stressful conditions, for example after exposure to H2O2. In
the nucleus, it binds to DNA (to the consensus
WWTRTCAT (W = A/T, R = G/A) sequence) as a
monomer through a basic region (BR) [18]. Of note, skn-1
gene encodes three splicing isoforms: SKN-1a, SKN-1b
and SKN-1c, which share many similarities but they have
also different expression patterns and functions (Fig. 2).
SKN-1a plays a role in the endoplasmic reticulum stress
response [19]. SKN-1b, expressed in a single pair of sen-
sory neurons, controls lifespan in dietary restriction [20].
Finally, SKN-1c is accumulated in the intestine and it
regulates expression of antioxidant and detoxification
genes during stress response [18].
The negative regulation of SKN-1 is distinct from Nrf2
in mammals. A functional equivalent of mammalian
Keap1, XREP-1 (WDR-23), was identified to control SKN-
1 activity [21]. This regulation is based on the recruitment
of SKN-1 to the CUL4/DDB1 (cullin 4/damaged DNA
binding protein 1) ubiquitin ligase in nucleus leading to
proteasomal degradation of this transcription factor and
stopping its activity [22].
Additionally, in Drosophila melanogaster cnc gene was
identified and named based on its striking expression pat-
tern in the anterior most labral segment (cap) and the
mandibular segment (collar) of embryos [23]. The cnc gene
encodes a bZIP transcription factor [23] and shares 60 %
similarity over 160 aa with the p45 subunit of the NF-E2
transcription factor [24]. This homology includes 95 %
identity in the 20 amino acid DNA-binding domain.
Moreover, the DNA-binding domain of cnc is also shared
with skn-1 [23].
Due to alternative splicing Cnc has three isoforms:
CncA, CncB and CncC which have distinct N-terminal
end, but share very homologous C-terminus harboring the
bZIP. Additional coding variants (longer isoforms) were
identified and reported in Flybase [25], but their functions
are not fully characterized. CncA and CncB are presumably
maternal and they are detectable at syncytial and early
cellular blastoderm stages, then they disappear until stage
14 [26]. CncA and CncC are required for germ cell via-
bility and early oogenesis [27]. The cncB is expressed in an
embryonic pattern that includes the labral, intercalary and
mandibular segments. CncB protein is 272 amino acids
longer than CncA isoform and it this part His-Pro, Ala,
Val-Gly and Pro repeats are present (Fig. 2). This differ-
ence on the N-terminus is essential for repressive effect on
Deformed (Dfd) response elements. CncC protein also
possesses this 272 amino acid domain, and it has additional
491 amino acids, enriched in Ser-Thr and Asp-Glu motifs,
at its N terminus that are unique to this isoform.
The molecular mechanism of stress response in insects
is similar to that described in mammals. In unstressed
conditions, CncC is retained in the cytoplasm by the actin-
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associated protein Keap1 [28]. Additionally, CncC activity
is limited by dKeap1, which serves as an adaptor protein
for Cul3-based ubiquitin ligase, targeting CncC for
degradation [29]. The comparison of amino acid sequence
homology between human Keap1 protein and Drosophila
dKeap1 is presented in the recent review by Pitoniak and
Bohmann showing conservation in BTB domain, linker
domain and also in Kelch-repeat domain (see review [25]).
Li and coworkers [17] have found that dKeap1 lacks
Cys226, Cys241, Cys249, Cys257, Cys319 but possess the
crucial Cys273 and Cys288, enabling dKeap1 to be fully
active.
In normal conditions, AREs are blocked by small Maf
(Maf-S) (musculo aponeurotic fibrosarcoma) protein [30,
31]. Maf-S does not have transcription activation domain,
and after its binding to ARE, target gene expression is not
activated. After stress exposure, electrophiles and ROS
disrupt interaction between CncC and Keap1. CncC is not
degraded and it is accumulated in the nucleus, where it
forms heterodimers with Maf-S, binds to AREs and acti-
vates target genes transcription [32]. This mechanism is
necessary for transcriptional responses to many xenobi-
otics, like chlorpromazine, caffeine or the pesticide
malathion [29] and represents evolutionarily conserved
mechanism of cell adaptations to stressful conditions.
In Drosophila, in contrast to mammals, where Nrf2
affects only phase II genes, CncC regulates the expression
of genes involved in every phase of detoxification. It is
important to remind that detoxification process may be
divided into three phases. Phase I is realized by many
enzymes, like cytochrome P450 monooxygenases, which
decrease biological activity of xenobiotics. Phase II is a
process of conjugation, when metabolites produced in the
phase I are linked with carboxyl-, hydroxyl-, amino-, or
sulfhydryl-groups. In this phase glutathione S-transferases
(GSTs) or UDP-glucuronosyltransferases (UGTs) play the
crucial role in the increase of hydrophilicity of xenobiotics
and carboxylesterases. Phase III is a final modification and
excretion, dependent on ATP-binding cassette (ABC) and
other transmembrane transporters. Misra et al. have found
that CncC causes changes in the expression of enzymes
involved in all phases of detoxification, including 36 dif-
ferent P450, 17 GSTs, six UGTs and 55 different
transporters [33]. It is worth to highlight that three P450
genes—Cyp6g1, Cyp6g2 and Cyp12d1—which are up-
regulated by CncC, are responsible for pesticide resistance
in insects [34, 35]. It was also shown that CncC/Keap1
pathway is constitutively active in insecticide-resistant
Drosophila strains [32]. An additional protection against
xenobiotics is CncC-dependent up-regulation of cuticle
gene expression [33]. CncC also regulates many metabolic
pathways which may be connected with detoxification. For
example, CncC up-regulates Zw and Pgd, encoding
glucose-6-phosphate dehydrogenase and phosphogluconate
dehydrogenase, respectively. These enzymes are involved
in pentose phosphate pathway and they are critical for
NADPH production, which is essential for P450 and GST
function [33]. Interestingly, Jones et al. showed that addi-
tional response to xenobiotics is provided by intestinal
Lactobacilli, causing ROS-dependent activation of Cnc
pathway [36].
In C. elegans oxidative stress causes accumulation of
SKN-1 in intestinal nuclei and activation of gene expres-
sion from I, II and III detoxification phase. Moreover,
SKN-1 induces the expression of C-type lectins, which are
localized on the intestinal surface and are known as
antimicrobial agents [37]. In addition, it has been suggested
that SKN-1 maintains lipid homeostasis and it may be
important for longevity [37]. This factor up-regulates lipid
metabolism genes in starvation or dietary conditions, which
induces fat mobilization. SKN-1 responds to elevated lipid
levels by activation of gene transcription involved in b-
oxidation, lipolysis, fatty acid desaturation, elongation, and
transport [38].
In summary, CncC in Drosophila, SKN-1 in nematodes
as well as vertebrate Nrf2 represent the same family of
conserved factors having the unique 43-amino acid CNC
domain located N-terminally to the DNA-binding domain
(Fig. 2). These factors modulate the stress response in
several scenarios, and therefore we discuss their potential
role in both the normal and pathologic conditions.
Role of Cnc transcription factors in development
Transcription factors belonging to the CNC-bZIP family
play a crucial role in an organism growth. SKN-1 is critical
for development of the endoderm and mesoderm, espe-
cially it initiates the formation of the digestive system and
other mesendodermal tissues in C. elegans. Interestingly,
SKN-1 is asymmetrically distributed within the embryo
(Fig. 3). In two-cell embryo skn-1 mRNA is deposited in
both cells [39], but protein is expressed at higher level in
the posterior cell. This asymmetry is regulated by EEL-1,
that is the Hect E3 ubiquitin ligase, targeting SKN-1 for
degradation [40]. In four-cell embryo these differences in
SKN-1 concentration are even more pronounced with high
level of SKN-1 in the posterior daughter cells. SKN-1
determines the mesendodermal EMS precursor cell [41,
42]. EMS divides into the mesodermal MS precursor that
develops into pharynx and muscles, and the E precursor
which generates all 20 intestine cells. SKN-1 directly
induces the expression of the transcription factors med-1
and med-2, which activate expression of the GATA factors
end-1 and end-3 in the E cell [43, 44]. In contrast, in the
MS precursor maternally deposited POP-1 inhibits END-1,
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3, and this results in blocking intestine development
pathway. Moreover, in MS cells MED-1,2 activate T-box
transcription factor tbx-35, that stimulates ceh-51, and then
together they initiate a pathway for mesodermal specifi-
cation [45, 46]. In the E precursor, POP-1 is modified
through Wnt-dependent pathway, and this decreases its
nuclear level and cooperation with b-catenin SYS-1 to
activate END-1,3 [47, 48]. END-1,3 cooperate each other
to activate elt-2, a crucial gene in intestine development
[49–51]. After the eight-cell stage, EEL-1 downregulates
SKN-1 and this protein is no longer detected in the early
embryo [18, 40].
The role of CNC factors is Drosophila development is
also well described. Cnc function starts during oogenesis,
when particular maternal mRNAs are deposited in oocytes.
These mRNAs are localized in a specific place of oocyte
and after fertilization they are translated for proteins, which
are necessary to form the anterio-posterior axis of embryo.
Maternally deposited Cnc (A or C isoform) is required for
proper microtubules positioning and affects anchoring of
the nucleus to the anterior cortex of the oocyte [52].
cncB transcription is activated in blastoderm and con-
tinuous during embryogenesis in two parts of embryo: the
anterior part called ‘‘cap’’ expression domain and in the
mandibular segment that corresponds to the ‘‘collar’’
domain [23, 53]. The specific cnc expression pattern results
from function of many genes, including knot (kn) [known
also as collier (col)] [54, 55], bicoid, torso, tailless (tll),
snail (sna), spalt (sal) and giant (gt) [56]. CncB controls
development of cephalic segments: the anterior compart-
ment of the mandibular segment and the labral segment
[23]. In mandibular development CncB cooperates with
homeotic Deformed (Dfd) gene. Tissues expressing CncB,
but not Dfd, form hypopharynx. In mandibular cells and in
some maxillary cells, CncB inhibits Dfd-activated gene
transcription. Of note, tissues expressing both CncB and
Dfd develop mandibular lobe-derived structures. Finally,
tissues expressing Dfd only, (but not CncB) drive maxillary
development [57]. Although the N-terminal of Cnc acts as
a strong transcriptional domain, CncB function requires
Maf-S protein, a homolog of the mammalian small Maf.
Maf-S can potentially form heterodimers with all Cnc
isoforms but, in contrast to the mammalian Maf protein, it
is not able to form homodimers and to bind to DNA itself.
CncB/Maf-S heterodimers bind a specific sequence
(TGCTGAGTCAT) that is very similar to the mammalian
Nrf/Maf binding site [31]. Other isoforms, CncA and
CncC, also affect embryogenesis, but their specific func-
tions are not well described yet [26].
CncB is also crucial for development of the pharynx and
it is a pharynx selector gene. In the labral and dorsal
pharyngeal region Cnc maintains the specific pattern of
segment polarity gene expression, hedgehog (hh) and
wingless (wg) [31, 58]. Both proteins Hedgehog and
Fig. 3 The role of SKN-1 in the development of C. elegans. In the
early embryo skn-1 mRNA is deposited in both cells: AB and P1, but
the level of SKN-1 protein is higher in the posterior cell (P1). This
asymmetry is regulated by EEL-1, which binds SKN-1 and targets it
to degradation mainly in AB cell. After division AB cell forms Aba
(anterior) and ABp (posterior) cells and P1 forms P2 and EMS cells.
In this four-cell embryo, SKN-1 is concentrated mostly in EMS cell.
In the next step, EMS divides into the mesodermal MS precursor,
which develop into pharynx and muscles, and the endodermal E
precursor, which generates intestine cells. SKN-1 increases level of
the transcription factors MED-1 and MED-2, which in turn activates
end-1,3 transcription. In MS cell POP-1 protein inhibits END-1,3,
whereas MED-1 and MED-2 activate transcription factors: tbx-35 and
ceh-51, which are crucial for mesoderm development. In E cell POP-1
is modified on Wnt/b-catenin-dependent pathway, what activates
END-1,3. END-1,3 cooperate with each other to increase the level of
ELT-2, which starts intestine development
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Wingless are necessary to the pharynx development. The
involvement of Cnc transcription factors in Drosophila
development is schematically summarized in Fig. 4.
In Drosophila, CncC controls also metamorphosis
through the regulation of ecdysone biosynthetic genes and
ecdysone response genes. In this pathway, CncC requires
Drosophila Keap1 (dKeap1) as a partner. Both, CncC and
dKeap1 are localized predominantly in the nucleus.
dKeap1 interacts with CncC and then binds to specific loci
(ecdysone-regulated early puffs) on the polytene chromo-
somes and maintains open chromatin structure that
facilitates transcription. The reduction of CncC or dKeap1
in the prothoracic gland, the organ producing ecdysone,
leads to the reduction of ecdysone biosynthetic gene tran-
scription, decrease in ecdysone level and delayed pupation.
CncC may also interact with Ras signaling pathway in
metamorphosis and transcriptional regulation. Phosphory-
lation of CncC in response to Ras and possibly other
signals can regulate the distribution of CncC on chromatin,
resulting in the regulation of development and metamor-
phosis [59, 60].
In Drosophila, Cnc is involved in the regulation of
intestinal stem cells (ISC) maintenance. ISC are the only
cells in the intestinal epithelium which proliferate and are
responsible for regeneration of the midgut. This process
needs to be precisely regulated because an excessive pro-
liferation in the intestine can result in disruption of the
intestinal epithelium by the accumulation of misdifferen-
tiated ISC daughter cells, as it has been observed in stress
conditions and aging. Hochmuth et al. showed that CncC-
Keap1 regulate ISC proliferation rates by influencing the
intracellular redox state. CncC is constitutively active in
ISC of young, unstressed flies and maintain low ROS level
leading to inhibition of ISC proliferation. In older flies, in
oxidative stress conditions, CncC activity is repressed by
Keap1, and increases proliferation rate [61].
In vertebrates, the regulation of the embryonic devel-
opment by Nrf transcription factors was examined in
several studies. It has been shown that deletion of Nrf1 in
mice leads to anemia, defects in erythropoiesis and death
[62]. In contrast to Nrf1, the inactivation of the Nfe2l2 gene
did not induce obvious defects in knockout mice, indicating
that Nrf2 is dispensable for growth and development [63].
Similarly, also Nrf3 knockout mice survive healthy [64].
Leung et al. [65] have observed that deficiency of both
Nrf1 and Nrf2 results in early embryonic lethality of mice
and this indicates a compensatory effect of Nrf1 in case of
Nfe2l2 knockout. Increased apoptosis has been observed in
embryos lacking both transcription factors and fibroblasts
isolated from Nrf1-/- Nrf2-/- mice exhibit increased
intracellular ROS levels and enhanced sensitivity to
oxidative stress.
Heme oxygenase-1 as an Nrf2-dependent gene
The Keap1-Nrf2 pathway regulates the expression of
numerous cytoprotective genes (Table 1) including
antioxidant ones, genes encoding enzymes that participate
in the synthesis and regeneration of glutathione, detoxify-
ing molecules, proteins that regulate the expression of other
transcription factors and growth factors and many more.
One of the genes regulated through Nrf2 is heme oxy-
genase-1 (HO-1, HMOX1, EC 1.14.99.3) [66]. HO-1 is one
of two distinct HO isoforms found in mammals. It serves as
an inducible 32-kDa protein, highly upregulated by a
number of stimuli like heme, nitric oxide, heavy metals,
growth factor, cytokines, modified lipids and others. In
Fig. 4 Cnc factors regulate
development of D.
melanogaster. Maternally
deposited Cnc has important
functions in egg polarization. In
embryo Cnc is concentrated in
the anterior part, in ‘‘cap’’ and
‘‘collar’’ domains. Cnc co-
operates with Dfd in tissue
development. In cells which
express both Cnc and Dfd, Cnc
forms heterodimers with MafS
protein, and inhibits Dfd
function. As the result,
mandibular structures develop.
Cells expressing only Dfd
develop into maxillary
structures. Finally, cell
expressing Cnc only form
pharynx structures
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contrast, HO-2 isoform is expressed constitutively (re-
viewed in [67]).
This cytoprotective enzyme catalyzes the rate-limiting
step in heme degradation, leading to the generation of
equimolar amounts of iron ions, biliverdin and CO (Fig. 5).
Biliverdin together with bilirubin, formed thanks to the
action of biliverdin reductase (BVR), are potent antioxi-
dants, but also the other products of HO-1 activity regulate
important biological processes including inflammation,
apoptosis, cell proliferation, fibrosis, and angiogenesis.
Iron is known to facilitate the generation of reactive oxy-
gen species through Fenton reaction and might be possible
toxic product of enzyme activity; however, already in
1992, Balla et al. [68] have shown that induction of HO-1
in endothelial cells exposed to H2O2-induced oxidative
stress is accompanied with induction of ferritin, a protec-
tive enzyme sequestering iron ions. Such association
between HO-1 and ferritin has been demonstrated also
Table 1 Cytoprotective genes regulated by Nrf2 transcription factor
Gene Abbreviation Major function
Ferritin Fn Sequesters free iron
Glucose-6-phosphate
dehydrogenase
G6PD Provides NADPH to gluthathione reductase
Gluthahione peroxidase GPx Detoxifies peroxides and hydroperoxides
Gluthathione S-tranferases GSTs Catalyze the conjugation of the reduced form of glutathione (GSH) to xenobiotic substrates
Gluthathione reductase GR Catalyzes the reduction of glutathione disulfide (GSSG) to the sulfhydryl form of glutathione
(GSH)
c-Glutamylcysteine ligase GCL Catalyzes the rate limiting step in the cellular glutathione (GSH) biosynthesis pathway
Heme oxygenase-1 HO-1 Degrades heme and generates the antioxidant molecules, biliverdin and CO
NAD(P)H:quinone
dehydrogenase 1
NQO1 FAD-binding protein, reduces quinones to hydroquinones
Sulfotransferases SULFs Catalyze sulfation of many xenobiotics
Superoxide dismutase SOD Catalyzes the dismutation of the superoxide radical (O2
-) into molecular oxygen (O2) or
hydrogen peroxide (H2O2)
Thioredoxin reductase TR Reduces thioredoxin
UDP-glucose dehydrogenase UGDH Converts UDP-glucose to UDP-glucuronate
Fig. 5 Heme oxygenase-1
pathway. HO-1, and inducible
enzyme, cooperating with
NADPH cytochrome P450
degrades heme to produce three
bioactive products: iron ions,
carbon monoxide and biliverdin,
which is rapidly converted to
bilirubin, through the action of
biliverdin reductase (BVR).
Tissue protection is exerted by
the activity of all products and
their functioning as a pro-
angiogenic, antioxidant or anti-
inflammatory factors
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in vivo, e.g., in the inflammatory glomeruli in human lupus
nephritis [69]. Both enzymes were expressed with similar
pattern in the glomeruli and what is more, the transcript of
ferritin heavy chain was decreased when HO-1 was
knocked down. On the other hand, the stimulation of HO-1
was able to exert only partial protective effect against
oxidative stress in cells lacking ferritin heavy chain, indi-
cating cooperation of both enzymes [69]. It seems that CO
is a major product of HO-1 activity playing a protective
role both in physiology and in pathological conditions (for
review see [70, 71]).
The importance of HO-1 has been underlined by the
studies on HO-1 knockout animals. Poss and Tonegawa
[72, 73] as well as Yet et al. [74] have created different
strains of HO-1-null mice. In 1999, Yachie et al., reported
the first known human case of HO-1 deficiency in 6-year-
old boy with severe growth retardation [75]. Another case
of human HO-1 deficiency was described 12 years later by
Radhakrishnan et al. [76]. The results from those human
cases of HO-1 deficiency generally confirmed animal
studies. The major symptoms observed in HO-1-deficiency
included enhanced systemic inflammation, abnormalities of
the coagulation/fibrinolysis system, developmental failure,
iron-deficiency anemia, intravascular hemolysis with
fragmented erythrocytes, nephropathy, and vascular
endothelial injury [75]. Almost the only one difference
observed in human and mice deficiency was the asplenia in
human case, whereas splenomegaly was noticed in the
young knockout mice. Thus, one can sum up that the
inadequate HO-1 level may result in a broad spectrum of
severe side effects, which could affect many organs (re-
viewed in [67]). This may also explain why only two cases
of human HO-1 deficiency have been described till now.
On the other hand, basal and induced expression of HO-
1 can vary in the human population because of the highly
polymorphic (GT)n fragment in the promoter, which may
significantly modulate cytoprotective, anti-inflammatory
and pro-angiogenic functions of HO-1 [77]. The distribu-
tion of alleles with different (GT)n lengths is bimodal
within the human population, with the most frequent
variants in Caucasians containing 23 and 30 repeats. The
results from many studies have clearly shown that longer
(GT)n sequences are associated with diminished HO-1
expression and lower resistance to oxidative stress. Short
(\25 GT) repeats are associated with higher HO-1 basal
expression and stronger up-regulation after stimulation
than longer repeats. The association between HO-1 poly-
morphism and occurrence/progression of some diseases,
mostly cardiovascular disease risk has been suggested
(reviewed in [67]). The recent study by Pechlaner et al.
[78] confirmed previously reported relations and showed
that subjects with C32 tandem repeats on both HO-1 alleles
display substantially increased cardiovascular disease risk
and enhanced atherosclerosis progression. However,
human genome epidemiology (HuGE) meta-analysis of
HO-1 polymorphism and susceptibility to coronary artery
disease (CAD) from 11 studies, involving 10,170 patients
with CAD and 6868 controls, performed in 2014 by Qiao
et al. [79] revealed no significantly decreased risk of CAD
in patients with the SS genotype of the HO-1 (GT)n repeat
length polymorphism compared with those with the
LL ? SL genotype. However, the results from the sub-
group analyses showed that the (GT)n SS genotype or S
allele were associated with decreased CAD risks in Asian
population and in studies with age- and sex-matched sub-
groups. Qiao et al. underlined that the lack of association
between HO-1 polymorphism and CAD in Caucasian
population found in their analysis may be at least partially
caused by some limitations of the studies performed, and
stressed the need of proper age and sex matching [79].
Besides cardiovascular disorders, the presence of long
(GT)n repeats has been suggested to be a prognostic marker
for several cancer, but overall the results are complex. In oral
squamous cell carcinoma [80], gastric adenocarcinoma [81]
and lung adenocarcinoma [82] the lack of short allele cor-
responds with a higher incidence of cancer. On the other
hand, in pancreatic cancer patients, an increasing risk was
evident between LL, SL, and SS genotype, with the latter
genotype displaying themost aggressive tumor biology [83].
Also in melanoma patients the homozygous short allele with
\25 (GT)n repeats (S/S) has been found more frequently in
the melanoma group compared to the healthy control pop-
ulation and this genotype characterized tumors with deeper
Breslow thickness compared to L-allele carriers [84].
However, similarly to cardiovascular disorders, the recent
meta-analysis has shown lack of the association between
HO-1 (GT)n repeat polymorphism and cancer susceptibility.
Zhang et al. [85] analyzed 10 studies involving 2367 cases
and 2870 controls and found that overall cancer risk was not
ascribed to the length of (GT)n sequence; however, some
sub-group analysis revealed higher risk of squamous cell
carcinoma in persons carrying longer (GT)n repeats in the
HO-1 gene promoter. Nevertheless, in recent study, Wu
et al. have found that participants with the SS genotype had
an increased risk of lung squamous cell carcinoma versus
those with L/S or L/L genotype. Moreover, in S/S genotype,
higher incidence of Bowen’s disease and invasive skin
cancer has been observed, while the participants with the
S-allele had a reduced risk of lung adenocarcinoma versus
those with L/L genotype [86].
Interestingly, the length of (GT)n repeats in the HO-1
promoter did not influence the onset of neurodegenerative
diseases such as Alzheimer’s disease (AD) and Parkinson’s
disease (PD) [87, 88]. However, Infante et al. have shown
that a -413 A/T single-nucleotide polymorphism (SNP) in
HO-1, together with glycogen synthase kinase-3b (GSK3b)
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(-157, rs6438552) TT genotype had four times higher risk
of developing PD than subjects without these genotypes
[89].
Role of HO-1 in embryogenesis and pregnancy
It is well established that HO-1-deficiency results in
embryonic death and some studies evaluated the role of
HO-1 in embryonic survival. HO-1 is expressed in the
placenta and in the pregnant uterus already on embryonic
day 6.5 (E6.5) [90]. Placenta of E14.5 embryos expresses
very high levels of HO-1 mRNA, protein and activity [90].
Similarly, rat placenta expresses high HO-1 at day 15 of
pregnancy [91]. Also in humans HO-1 is expressed in tro-
phoblast and is highly induced during pregnancy, being a
factor supporting pregnancy and decreasing abortions.
Moreover, reduced HO-1 level was shown to be associated
with miscarriages and pregnancy complication including
pre-eclampsia (reviewed in [92]). Interestingly, the mother
of the Japanese HO-1-deficient patient, was found to be
heterozygous for Hmox1 and she had experienced two
intrauterine fetal deaths [75]. Also experiments on mice
lacking both or one HO-1 allele support the crucial role of
HO-1 in placenta and in pregnancy. Zhao et al. observed
that HO-1 deficiency resulted in fetal lethality and
decreased litter sizes [93] and also our own group have
noticed abnormally low birth rate of HO-1-/- offspring,
born from HO-1?/- parents (unpublished data). Intrauterine
abortions of HO-1-/- embryos, observed regularly in HO-
1?/- cross-breedings, were reported to occur before E10.5
[93]. Additionally, the weight of placenta in HO-1?/- mice
was reduced due to the apoptosis in the spongiotrophoblast
layer. On the other hand, HO-1 overexpression was shown
to improve pregnancy outcome in mice [94]. The detailed
mechanisms responsible for HO-1 contribution to ovulation
and fertilization, implantation and placentation is elegantly
summarized in the recent review by Zenclussen [92].
In vivo experiments in rats showed the regulation of insulin-
like growth factor (IGF) binding protein-1 by placental or
trophoblastic HO-1 [95]. Noteworthy, IGF was reported to
enhance the blastocyst formation, increase the number of
blastomeres in cultured murine embryos, and to facilitate
the establishment of stem cell lines [96]. HO-1 may also
directly affect differentiation of pluripotent stem cells. Lin
et al. generated induced pluripotent stem cells (iPSc) from
embryonic fibroblasts, isolated from HO-1?/?, HO-1?/-,
and HO-1-/- mice, using Oct3/4, Sox2, Klf4 and c-Myc
reprogramming factors [97]. After prolonged cell culture,
the reduced expression of pluripotency markers in HO-1-/-
cells, increased sensitivity to oxidant-induced cell death and
augmented differentiation were detected [97].
Heme oxygenase system in prokaryotic
and eukaryotic species
As it was described above, Nrf2 transcription factor shares
high homology with their counterparts in Drosophila,
nematodes or zebrafish, but importantly, they are not pre-
sent in plants and fungi. In contrast, there is a high degree
of evolutionary conservation of the heme-degrading
enzymes among animal, plant, and fungal kingdoms. In
vertebrates, the structural similarity and functional identity
between HO enzymes is reported. Moreover, in bacteria,
fungi, plants and flies, HO-1-like proteins or analogs have
been identified.
Generally, in the mechanism of HO-catalyzed heme
cleavage to a-isoform of biliverdin, CO and iron is uni-
versal among bacteria, fungi, plants, insects, and mammals.
However, some differences might be present, when
cofactor requirements or overall functional significance of
heme metabolism between various organisms are
discussed.
In D. melanogaster, HO-1 homolog (dHO) has been
shown to degrade heme to biliverdin, CO and iron in the
presence of reducing systems such as NADPH/cytochrome
P450 reductase and sodium ascorbate, although the reac-
tion rate is slower than that of mammalian HOs [98].
Interestingly, three isomers of biliverdin, biliverdin-IXa
and two other isomers (IXb and IXd) are formed [98]. dHO
has been shown to be not induced by stress stimuli; how-
ever, it is expressed in the brain in the circadian pattern
[99, 100]. ho knockdown is lethal at larval stage, what
suggests that dHO is essential for normal development
[99]. The tissue-specific ho knockdown in the eye imaginal
disc causes abnormalities in the eye morphology as well as
of iron accumulation in the compound eye of adult flies.
Surprisingly, heme is not accumulated in dHO-deficient
tissues, due to decrease in the heme biosynthesis pathway,
because the expression of delta-aminolevulinic acid syn-
thase, the first enzyme of the heme-biosynthetic pathway is
lowered in larvae as well [99].
In plants, the first HO homolog was identified in the red
algae Cyanidium caldarium [101] and this enzyme was
shown to generate biliverdin-IXa that is utilized for the
phycobilin synthesis instead of the bilirubin production
(generally, plants which lack the equivalent of mammalian
BVR do not produce bilirubin) [102]. In Arabidopsis
thaliana, HY1 gene encodes a homolog of HO-1, and
shows high sequence similarity to mammalian and
cyanobacterial HOs as well as it possesses HO activity
in vitro [103]. This homolog utilizes ferredoxin as the
reducing partner instead of NADPH:cytochrome P-450
reductase [103], to generate biliverdin-IX as a precursor for
the synthesis of light-harvesting pigments. Further analysis
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has underlined the existence of four members of HO family
in Arabidopsis thaliana (HY1, HO2-4) [104]. Two sub-
families based on amino acid sequence alignments have
been proposed: one subfamily includes HY1, HO3, and
HO4 with the canonical HO active site, and another sub-
family contains just HO2, which lacks the conserved
histidine residue considered to be an important ligand for
heme binding. The differences in the level of specific
members were studied by Matsumoto et al. who showed
that in Arabidopsis HO1 is the highly expressed, followed
by lower level of HO2 and the lowest HO3 and HO4 [105].
In plants, the up-regulation of HO1 was observed in
response to many agents, including light, UV, ROS, iron
deprivation or cadmium (Cd), leading to the increased
biosynthesis of phytochrome (phy) chromophore and thus
being essential for proper photomorphogenesis. HO1 can
also play a role in the protection against oxidative stress.
For example, in soybean nodules, the treatment with
200 lM Cd caused tenfold induction of HO activity along
with increased oxidative stress. Importantly, co-adminis-
tration of 10 lM biliverdin completely prevented the
effects caused by Cd, indicating a potent anti-oxidant
activity of BV. On the other hand, the application of zinc
protoporphyrin (ZnPPIX), an HO-1 inhibitor, significantly
enhanced oxidative stress parameters [106].
Of note, heme oxygenases are present in prokaryotes as
well (for review see [107]). Cyanobacterial HOs, e.g.,
isolated from Synechocystis sp. PCC6803, HO-1 and HO-2
are the best characterized bacterial HOs. In heme-utilizing
bacterial pathogen Corynebacterium diphtheriae, HmuO
enzyme has been shown to share 33 % sequence identity
and 70 % homology to the human HO-1 [108]. On the
other hand, HemO identified as the gene involved in the
utilization of the host’s heme as an iron source and isolated
from Gram-negative pathogen Neisseriae meningitides
shows low sequence identity to other HOs [109].
The key functions in the catabolism of heme, regulation
of oxidative stress, synthesis of phytobilins, bacterial
pathogenesis and iron acquisition are only some of the
numerous biological roles played by HOs in prokaryotes
and eukaryotes.
Cnc transcription factors may play a special role
as pro-longevity and anti-aging factors
Nrf2 has been suggested as ‘‘a guardian of health span and
gatekeeper of species longevity’’ [110]. Also in D. mela-
nogaster CncC was demonstrated to be involved in aging
processes, since older flies progressively lose the ability to
CncC-targeted activation in response to stress. On the other
hand, the expression of CncC target genes in unstressed
conditions does not decrease in older flies [111].
Several mouse models of extended longevity have been
utilized to check the role of Nrf2 in this process. The study
performed in mice under calorie restriction, which is
known to extend lifespan and delay many aspects of aging
[112], showed that the lack of Nrf2 does not attenuate
lifespan extension [113]. On the other hand, Nrf2 was
prerequisite for cancer-preventive effects after the reduc-
tion of calories by 20–40 % [113]. However, experiments
performed on C. elegans, indicate that the extended long-
evity of diet-restricted worms results from SKN-1 acting in
special neurons, the ASIs. They signal to peripheral tissues
to increase their metabolic activity [20]. The recent study
by Smith-Vikos et al. identified the specific microRNAs
that are critical for the dietary restriction-induced lifespan
extension in C. elegans. miR-71 and miR-228 are induced
by the calorie restriction and the regulation of these
microRNA depends on SKN-1 [114]. Importantly, miR-71
has been shown to promote longevity because miR-71 loss-
of-function mutants have significantly shorter lifespan than
wild-type, and overexpressing miR-71 increases lifespan
[115].
SKN-1 mutants have the shortened lifespan and oppo-
sitely, overexpression causes the extension of lifespan [18,
116]. Moreover, similarly to Drosophila, the expression
level of SKN-1-regulated genes decreases with aging.
SKN-1-mediated regulation of collagen expression which
is necessary to extracellular matrix remodeling seems to be
very important for aging and longevity [117]. This process
is connected with the reduced insulin signaling in older
animals, which normally regulates SKN-1 activity [118,
119]. SKN-1 is also involved in lifespan extensions in
response to reduced activity of the mechanistic target of
rapamycin (mTOR) signaling [120, 121].
Palikaras et al. showed that longevity depends on
homeostasis between mitophagy (an autophagy type tar-
geting mitochondria for degradation) and mitochondrial
biogenesis in C. elegans. This process is regulated by SKN-
1 by enhancing DCT-1 expression, a C. elegans homolog
of mammalian BNIP3 and BNIP3L/NIX, key mediators of
mitophagy [122, 123], for review see [124].
Interestingly, in the model of Keap1 inactivation in D.
melanogaster, males showed the higher survival rate after
paraquat (a free radical generator) exposure. Moreover,
under standard culture conditions, male keap1-/?
heterozygote flies live significantly longer than their sibling
controls [29]. In addition, in Ames dwarf mice and Little
mice, the models of delayed aging, showing significant
increases in lifespan (50 and 25 %, respectively), the
enhanced activity of detoxification enzymes and antioxi-
dant proteins including GST (Nrf2-target gene) in
comparison with their control counterparts was observed
[125]. The recent study performed in ten rodent species,
ranging in the maximum lifespan potential (MLSP)
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between 4 and 31 years, has shown that in the long-lived
naked mole rats there is a constitutively high level of Nrf2
in comparison to other rodent species with shorter lifespan
[126]. On the other hand, Keap1 inhibitory protein was
negatively correlated with MLSP in rodents, and it was
almost not detected in liver of naked mole rats, whereas in
laboratory mice Keap1 effectively halts Nrf2 activity [126].
The level of Nrf2-regulated genes, like those encoding HO-
1, NQO1 or GSTA1, was also potently increased in naked
mole rats in comparison to normal-living mice [126]. The
summary of age-related changes in the Nrf2 regulatory
system is shown in Fig. 6.
Role of CncC/SKN-1/Nrf2 in proteasome
regulation
During aging, a multifactorial process modulated by the
interplay between genetic and environmental factors, the
functionality of proteasomes declines in both the somatic
tissues of Drosophila [127] and in mammalian cells [128].
The proteasome 26S is a complex of proteins composed of
the proteolytic core (20S protein) flanked by regulatory
particles, mostly ATPases (19S proteins), which acquire
substrates and direct them into the proteolytic chamber.
The 26S proteasome is mostly involved in the ATP-de-
pendent degradation of normal short-lived ubiquitinated
proteins, whereas the 20S proteasome itself degrades oxi-
dized or damaged proteins [129]. A protein that is targeted
for degradation is modified by E1, E2, E3 enzymes binding
ubiquitin and a poly-ubiquitin chain is attached to the
target protein. The 26S proteasome recognizes the poly-
ubiquitin chain linked to the target protein and marks it as a
substrate for hydrolysis (Fig. 7). This pathway is involved
in the regulation of numerous cellular mechanisms,
including protein quality control, transcription, cell-cycle
regulation, DNA repair, signal transduction, antigen pre-
sentation and degradation of mutated proteins involved in
the progression of many disorders, e.g., tumor development
[130].
In Drosophila, CncC was identified as a candidate
transcriptional regulator of proteasome component
expression [131]. ARE-enhancer sequences, a target for
CncC, are present in proteasome genes Rpn1 and Beta-2,
within location described as crucial for induction of pro-
teasome gene transcription after treatment with an inhibitor
in experimental conditions [132]. CncC is also involved in
the increased 20S and p97 ATPase expression, but does not
affect 26S. Similarly to mammals, Drosophila cells that are
pre-treated with hydrogen peroxide adapt to oxidative
stress by CncC-dependent up-regulation of the proteolytic
activity and 20S proteasome expression [133]. Finally, it
has been shown that age-dependent decrease in proteasome
expression is related to CncC dysfunction in older flies
[127, 134]. Tsakiri et al. showed that knockdown of 20S
proteasome subunits causes lethality of larva [134]. The
proteasome dysfunction observed in adults promotes ‘‘old-
age’’ phenotypes and reduces the lifespan. These changes
result from dysfunctions of CncC as cncC silencing
reduced proteasome activity, stress resistance and long-
evity, while cncC up-regulation had the opposite effect.
Interestingly, the prolonged cncC overexpression reduces
longevity [134]. In another paper, Tsakiri et al., it was
demonstrated that proteasome genes are differentially
expressed in somatic and reproductive aged tissues and
these changes are Cnc/Keap1-dependent [127]. Gonads of
young flies had more active proteasomes than somatic
tissues, and they were, independently of age, more resistant
Fig. 6 Nrf2 activity decreases
with aging. Age-related changes
in the Nrf2 regulatory system,
including increase in Bach1 and
Keap1 lead to the inhibition of
Nrf2 activity and downstream
effects
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to oxidative stress. Additionally, the knockdown of keap1
caused youthful proteasome gene expression level in aged
somatic tissue, whereas cncC silencing resulted in the
decreased proteasome gene expression in aged gonads,
similar to that observed in normal aged somatic tissues.
These findings explain the mechanism of ‘‘immortality’’ of
reproductive cells, in which proteasome gene expression is
high even in old animals [127].
The mechanism of enhanced proteasomal activity by
Nrf2-induced gene expression represents the fundamental
strategy in the protection against oxidative stress not only
in flies, but also in nematodes and mammals. The worm
orthologue of Nrf2, SKN-1 can promote longevity under
reduced insulin/IGF-1-like signaling, dietary restriction,
and normal conditions [116, 135].
SKN-1 and Nrf2 are involved in the adaptation to
stressful conditions through the induction of the 20S pro-
teasome [133]. In their recent study, Chondrogianni et al.
demonstrated that up-regulation of the 20S proteasome
levels, assembly, and activity results in C. elegans lifespan
extension and increased resistance to stress [136]. Note-
worthy, the extension of lifespan was dependent on the
transcriptional activity of SKN-1 as well as the other fac-
tors like Dauer formation abnormal/Forkhead box class O
(DAF-16/FOXO), and heat shock factor-1 (HSF-1) [136].
The involvement of DAF-16 (FOXO) in SKN-1 effects was
also suggested by Wang et al. [135]. In mammalian cells,
the activation of Nrf2 by sulforaphane (SFN) leads to
increase of 20S proteasomal activity and to augmented
expression of the 20S catalytic subunit gene, PSMB5 but
this regulation is not present in the fibroblasts from Nfe2l2-
disrupted mice [137]. Not only the 20S proteasome, but
also increased level of the Pa28ab (or 11S) proteasome
regulator was reported to be regulated by Nrf2 as the
adaptive response of the cells.
Role of Nrf2/HO-1 in age-dependent diseases
As mentioned above, Nrf2 signaling pathway is essential
for xenobiotic and oxidative stress responses and it plays a
protective role in many different organs, and prevents
kidney, liver, nervous system, lungs and other organs from
the toxic insults. As oxidative stress is believed to con-
tribute to aging, it could be easily predicted that Nrf2
system may function in the prevention of age-related dis-
eases. Moreover, as discussed earlier, increasing
proteasome activity might represent anti-senescence ther-
apy and the defective ubiquitin/proteasome pathway
leading to protein aggregates that is observed in many
neurodegenerative disorders, suggesting a possible protec-
tive role of Nrf2/HO-1 system.
Fig. 7 CncC/SKN-1/Nrf2 involvement in the regulation of protea-
some. The Nrf2-dependent up-regulation of the proteasome levels,
assembly, and activity may result in the adaptation to stressful
conditions, lifespan extension and increased resistance to stress.
The regulation of proteasome genes (Rpn1, Beta-2, 20S, p97) is
indicated
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Neurodegeneration
The basic research on the role of Nrf2 in astrocytes, neu-
rons and other neuronal cells indicates the neuroprotective
role of this transcription factor. Importantly, aging may
affect Nrf2 level, and the reduction of Nrf2 mRNA and
protein results in impaired Nrf2 signaling. Suh et al. [138]
indicated that the level of Nrf2 and the expression of Nrf2-
mediated c-glutamylcysteine ligase (GCL) and glutathione
(GSH) level in old (24–28 months) rats decrease potently
in comparison to young (2–5 months) animals. In 2009,
Duan et al. using in vitro and in vivo models, clearly
showed that with aging, the level of Nrf2 as well as Nrf2-
dependent genes, including HO-1, decreases in the mouse
spinal cord and astrocytes [139]. Moreover, Suzuki et al.
have found that Nrf2 level decreases in macrophages from
older smokers in comparison with older nonsmokers.
Simultaneously, the level of Keap1 and Bach1, the Nrf2
repressors increases in lungs [140].
The augmented oxidative stress is associated with death
of cells of the nervous system in the pathogenesis of neu-
rodegenerative diseases such as Alzheimer’s disease (AD),
Parkinson’s disease (PD), Huntington’s disease (HD) or
amyotrophic lateral sclerosis (Lou Gehrig’s disease).
In vitro studies clearly indicate that chemical inducers of
Nrf2, like tBHQ and SFN or its adenoviral overexpression
in astrocytes results in protection against hydrogen perox-
ide-induced oxidative stress [141, 142]. On the other hand,
experiments performed in Nrf2-deficient cells and Nrf2
knockout mice showed they are significantly more vul-
nerable to striatal damage reminiscent of HD [143]. A
similar increase in the sensitivity of the Nrf2-deficient mice
has been observed in models of PD. The neurotoxin
6-hydroxydopamine (6-OHDA) both in vitro and in vivo
showed a greater effect in Nrf2-deficient cells than in wild-
type counterparts [144]. Similarly, in the 1-methyl-4-phe-
nyl-1,2,3,6-tetrahydropyridine (MPTP) animal model of
PD, the greater loss of dopamine transporter levels in the
striatum of Nrf2 knockout mice than in wild-type at all
MPTP doses tested was observed [145, 146]. Moreover,
Nrf2 activation by SFN protects against MPTP-induced
death of nigral dopaminergic neurons, leading to decrease
in astrogliosis, microgliosis, and release of pro-inflamma-
tory cytokines [147]. Interestingly, HO-1-/- mice have
been shown to be similarly sensitive to MPTP as wild-type
littermates [146], although the previous studies showed
ample evidence for neuroprotective activities of HO-1, e.g.,
adenoviral overexpression of HO-1 increased significantly
the survival rate of dopaminergic neurons in the rat model
of PD [148]. Of note, as mentioned above, some studies
indicate that carriers of -413 A/T SNP in HO-1 together
with TT genotype of GSK3b had four times higher risk of
developing PD than subjects without these genotypes [89].
In flies, CncC can also protect from neurodegeneration,
as it has been shown in the Drosophila model of PD. The
chemical agents, SFN and allyl disulfide, inhibit neu-
rodegenerative changes by induction of CncC activity
[149]. It has also been shown that decaffeinated coffee
and nicotine-free tobacco (but not caffeine and nicotine
alone) have neuroprotective effect on flies with overex-
pression of human a-synuclein or in parkin mutant
(models of PD), as well as in the fly’s models of AD and
polyglutamine disease. This effect is mediated by Cnc, as
it has been proved by silencing cnc transcripts that sup-
pressed the cytoprotective effect of coffee and tobacco.
Moreover, the Cnc activator present in coffee, called
cafestol, is able to protect neuronal cells against death in
transgenic a-synuclein flies. Cafestol can induce gstD1-
GFP that is used as a reporter of Nrf2 activity [150].
Barone et al. claim that the Cnc overexpression in
dopaminergic neurons is sufficient to counteract a-synu-
clein toxicity [151]. In the recent paper by Wang et al.,
transgenic flies with mutated a-synuclein (A53T), show-
ing neurodegenerative changes characteristic for PD, were
protected by bardoxolone methyl (CDDO-Me), Nrf2
inducer, through ROS scavenging and the activation of
Nrf2/antioxidant response element signaling pathway.
Furthermore, the selective expression of CncC in
dopaminergic neurons effectively protected against the
neurodegenerative phenotype of the A53T a-synuclein
flies [152].
The involvement of Nrf2 in the AD development seems
to be associated with the disease progression. Several
studies have shown the increase in the expression levels of
Nrf2-target genes, including HO-1 during AD progression
[153, 154]. The another studies showed a potent up-regu-
lation of HO-1 in glial cells of AD patients [155]. In
addition, the inhibition of HO-1 by azole-based, a brain-
permeable inhibitor of HO-1, OB-28, led to the significant
improvement in a complex maze learning task relative to
saline-treated controls, indicating the amelioration of
behavioral anomalies in the transgenic mouse model of AD
through HO-1 down-regulation [156]. However, in 2007,
Ramsey and colleagues have observed the decrease in
nuclear Nrf2 expression in the affected brain regions of AD
patients [157]. As it was suggested by Yamazaki et al., in
the early stages of AD, Nrf2 is up-regulated by b-amyloid-
induced ROS, whereas during the disease progression Nrf2
level starts to decrease [158].
The neuroprotective role of Nrf2 is based also on the
results from dimethyl fumarate (DMF) action in multiple
sclerosis (MS). MS is a chronic, devastating, autoimmune
disease manifested by the demyelination of neuronal axons.
Inflammation and oxidative stress together with neurode-
generation contribute to disease progression (reviewed in
[159]).
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The protective role of DMF in MS pathology is sup-
ported by both in vitro and in vivo studies as well as by the
results of large clinical trials (CONFIRM and DEFINE)
[160]. Based on those experiments it was suggested that
DMF does not have a single mechanism of action, but
rather exerts a multitude of biological effects. It possess
anti-inflammatory potential through shifting the cytokine
profile from Th1 toward a Th2 profile as well as it was
shown to inhibit the activation of NF-jB and pro-inflam-
matory IL-6 and IL-12 (reviewed in [161, 162]).
Additionally, in 2011, Linker et al. demonstrated that
beneficial effects of DMF in murine experimental
autoimmune encephalomyelitis (EAE), a mouse model of
MS are mainly due to activation of Nrf2 [163]. Many other
papers showed that the regulation of Keap1 and Nrf2
activation, resulting in transcription of HO-1 or NQO1 is
responsible for neuroprotective effect of DMF (reviewed in
[161]).
Importantly, the DMF analog, BG-12 (brand name
TecfideraTM) was approved in 2013 for the treatment of
relapsing-remitting MS by the European Union and the US
Food and Drug Administration [160]. Not only MS patients
may be treated by DMF, as it reduces psoriasis symptoms
[164] as well it might protect against systemic and CNS
complications in HIV infection through its effective sup-
pression of immune activation, oxidative stress, HIV
replication, and macrophage-associated neuronal injury
[165].
Several possible mechanisms could be responsible for
the neuroprotective activity of Nrf2 (Fig. 8). First of all, the
induction of protective genes, like those encoding HO-1
and GCL or GSH synthetase may be a major component of
the protection against oxidative stress exerted by Nrf2
[142]. Nrf2 is also crucial for injury-induced neurogenesis
in the hippocampus, regulating proliferation and neuronal
differentiation of neural stem/progenitor cells [166]. Pos-
sibly, Nrf2 may protect from mitochondrial dysfunction
and prevent from increased ROS generation and death of
neural cells. In addition, the control of neuroinflammation
by Nrf2, and the inhibition of pro-inflammatory factors,
like IL-6 or iNOS as well as the up-regulation of anti-
inflammatory IL-10 may contribute to this effect. More-
over, Nrf2 may modulate autophagy since defective
autophagic system is known to be pathogenic in neurode-
generative disorders like AD [167].
As mentioned above, under normal conditions, Nrf2 is
bound to Keap1 and is inactivated as a transcription factor
for antioxidant defense genes by proteasome-mediated
degradation. Under oxidative stress, Keap1 can be modified
through oxidative-dependent mechanism and it can no
longer bind Nrf2. It might also be sequestered by p62, a
ubiquitin-binding protein acting as a scaffold for several
protein aggregates and triggering their degradation through
the proteasome, or the lysosome pathway via autophagy
[168, 169]. In 2010, the non-canonical pathway of Nrf2
activation, relying on redox-independent interaction
between Keap1 and p62 was suggested [168]. Lau et al.
have shown that accumulation of endogenous p62 or
ectopic expression of p62 sequester Keap1 into aggregates,
resulting in the inhibition of Keap1-mediated Nrf2 ubiq-
uitination and its subsequent degradation by the
proteasome [168]. Moreover, phosphorylation of p62 at
Ser351 increases its binding affinity for Keap1, leading to
the increased expression of cytoprotective Nrf2 targets
[170]. Jain et al. identified p62 as a direct Nrf2-regulated
gene as Nrf2 binds to ARE sequence in the p62 promoter,
leading to its increased expression [171]. In turn, in
genetically modified mice with decreased 26S proteasome
Fig. 8 Neuroprotective activity of Nrf2. Nrf2 mediates neuroprotec-
tion through several possible mechanisms. The reduction of oxidative
stress, modulation of inflammation as well as autophagy process may
contribute to protective effects of Nrf2 in the nervous system. Of note,
p62 may directly activate Nrf2 through sequestration of Keap1
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activity, the activation of autophagy and the Keap1-Nrf2
pathway represent the defense mechanisms that is able to
adapt to impaired proteasome function [172].
Age-related macular degeneration
Oxidative stress might be also one of the main factors
contributing to the pathogenesis of age-related macular
degeneration (AMD), characterized by the damage of the
retinal pigment epithelium (RPE) cells and photoreceptors
(Fig. 9). In aging Nrf2 KO mice degeneration of RPE cells
resembling human AMD is evident with defects in lyso-
zyme-dependent degradation leading to less efficient
removal of oxidatively damaged protein aggregates
through deregulated autophagy [173]. Interestingly, the
25129A[C polymorphism of the Nrf2 gene has been sug-
gested to be associated with AMD [174]. Similarly, the
genetic variation in HO-1 gene may affect the pathogenesis
of AMD through the modulation of the cellular reaction to
oxidative stress. It has been suggested that 19G[C-HO-1
polymorphisms may be associated with the occurrence and
progression of AMD [175].
The possible link between Nrf2, AMD and cigarette
smoking, the latter known to be involved in the pathology
of AMD [176], has been studied by Wang et al. [177].
Indeed, Nrf2 deficiency magnified the effect of cigarette
smoking on inflammatory response and complement
activation, the effects contributing to drusen formation
[177]. On the other hand, in vitro experiments performed
on ARPE-19 cells exposed to cigarette smoke extract
(CSE) or hydroquinone (HQ), a component of cigarette
smoke, showed that the increased oxidative damage and
apoptosis, is manifested by HO-1 up-regulation and pos-
sibly iron accumulation [178]. Given the evidence that
iron accumulation within the eye may account for
pathological progression of AMD [179], the very high
activity of HO-1 caused by CSE may affect AMD
pathology.
The direct comparison of young (2 months) and old
(15 months) mice under unstressed and sodium iodate-
stressed conditions, that is the frequently used model for
the retinal degeneration [180], have underlined the
involvement of Nrf2 signaling in the pathogenesis of the
disease [181]. The retinal pigment epithelium of old mice
exhibited impaired induction of Nrf2-dependent genes in
response to the toxic insult. On the other hand, genetic
enhancement of Nrf2 activity by the conditional knock-
down of the Nrf2 negative regulator Keap1, partially
restores Nrf2 signaling through the increased NQO1
expression in old mice [181].
Cancer
Growing body of evidence suggests that Nrf2 is involved in
the chemoprevention of normal cells but also promotes the
growth of cancer cells. Similarly, HO-1 involvement in
Fig. 9 Age-related macular
degeneration and Nrf2.
Decrease in Nrf2 and increase in
Keap1 levels as well as Nrf2
and HO-1 promoter
polymorphism contribute to
damage of the retinal pigment
epithelium (RPE) cells and
photoreceptors. Nrf2 deficiency






3236 A. Loboda et al.
123
cancer progression is well documented, but also HO-1 may
be protective for cancer cells at least in some tumor types.
Noteworthy, ROS are involved in both tumor initiation
as well as in tumor progression, causing nucleic acid
alterations, both sugar and base modifications in nuclear but
also in mitochondrial DNA that is more prone to mutations
due to the lack of histones [182]. In tumors, the production
of ROS is exacerbated through the increased mitochondrial
activity and accelerated metabolism of tumor cells. ROS
scavenging through the Nrf2-mediated induction of target
genes might be a protective mechanism of action of many
natural and synthetic compounds used as chemopreventive
agents, which are able to stop or delay the occurrence of
malignancy (Fig. 7). The examples include oltipraz,
oleanolic acid (OA) and its synthetic derivatives, like
CDDO-imidazole (CDDO-Im) (1-[2-cyano-3-,12-diox-
ooleana-1,9(11)-dien-28-oyl] imidazole) or SFN (reviewed
in [183, 184]). In our hands, some synthetic derivatives of
OA increased Nrf2 activity and its target gene expression,
but we also observed cell-type specific response to other
triterpenoid, betulin on Nrf2 activation in keratinocytes and
endothelial cells [183]. Additionally, the beneficial, Nrf2-
dependent effects have been clearly presented in many
in vitro and in vivo studies also using Nrf2-deficient cells/
animals. The effectiveness of Nrf2 inducers has been
assessed in clinical trials. However, oltipraz as well as the
CDDO-derivative, bardoxolone methyl, because of serious
side effects reported in some trials, like BEACON—
bardoxolone methyl evaluation in patients with chronic
kidney disease and type 2 diabetes (ClinicalTrials.gov,
NCT01351675), have been withdrawn from clinics. The
plethora of data from Nrf2 KO mice suggest greater sus-
ceptibility of such mice to carcinogenic insults, like
N-nitrosobutyl(4-hydroxybutyl)amine (BBN)-induced
bladder carcinogenesis [185], aflatoxin-induced human
hepatocellular carcinomas (HCCs) [186] or ultraviolet-
triggered skin carcinogenesis [187].
Although the positive, protective effect of Nrf2 has been
reported mostly during tumor initiation, it is now well
documented that this transcription factor has a dual role in
tumorigenesis. In the last years, an increasing number of
studies have examined the oncogenic properties of Nrf2
(reviewed in [188]) as shown in lung cancer [189], squa-
mous cell carcinomas of esophagus and skin [190] or
hereditary leiomyomatosis and renal cell cancer (HLRCC)
[191]. HLRCC is caused by a mutation of fumarate
hydratase (FH), the Krebs cycle enzyme, functioning as a
tumor suppressor gene and the inactivation of FH initiates
formation of multiple renal cysts. Adam et al. showed that
the formation of cysts in FH-deficient mice is dependent on
Nrf2 and on the modification of Keap1 [191]. In lung
cancer, loss of Keap1 function leading to constitutive
activation of Nrf2-mediated gene expression caused
enhanced transcriptional induction of antioxidants, xeno-
biotic metabolism enzymes, and drug efflux pumps and
promotes tumorigenesis [189]. Of note, mutation of Keap1
leading to its inactivation is a frequent genetic alteration in
non-small-cell lung carcinoma (NSCLC) [189].
Similarly, HO-1 demonstrated pro-tumorigenic effects
in many cancers. HO-1 was shown to increase tumor cells
proliferation and migration and prevent cancer cells from
apoptosis and autophagy (for review see [192]). The reg-
ulation of blood vessel formation and the increase in the
expression of pro-angiogenic factors are also regulated in
HO-1 dependent way ([193–195], reviewed in [67, 196]).
The positive correlation between the progression of tumors
and increased HO-1 expression was noted for many
tumors, including prostate cancer, renal cancer, glioma,
melanoma, pancreatic cancer, Kaposi sarcoma and others
(for review see [196]).
Recent studies underlined the possible link between
oncogenic mutations and HO-1 induction. Hmox-1 gene
expression is induced upon expression of oncogenes asso-
ciated with the induction of some types of cancer. In
Kaposi sarcoma, HO-1 mediates the oncogenic G protein-
coupled receptor (vGPCR) oncogene-induced transforma-
tion associated with the increased vascular endothelial
growth factor (VEGF) synthesis [197, 198]. The other
study indicates the link between HO-1 and Bcr/Abl fusion
gene in chronic myelogenous leukemia (CML) [199],
whereas in kidney cancer the activation of Ras pathway
and the stimulation of downstream signaling, including Raf
and ERK, lead to Nrf2 activation and HO-1 induction
[200]. In addition, Drosophila was used as a model for
studying link between Myc, a pro-oncogenic transcription
factor which has been found to be deregulated in a large
number of different cancer types, and Nrf2. Nagy et al.
have reported that the activation of Cnc/Nrf2 is required for
Myc-induced overgrowth and this effect is related to the
autophagy unfolded protein response induction, p62 accu-
mulation and Nrf2 activation [201]. In 2010 it was already
published, that p62 activation, through the constant acti-
vation of antioxidant response via the disruption of the
interaction between Keap1 and Nrf2, leads to tumorigen-
esis [169]. The Myc-induced overgrowth in Drosophila is a
consequence of both increased autophagy and antioxidant
response. In mammals, the direct interaction of c-Myc and
Nrf2 and c-Myc-dependent negative regulation of phase II
genes was demonstrated [202]. The cross-talk between
Nrf2 and other transcription factors playing an important
role in cancer cell biology has to be also underlined. We
have demonstrated that the regulation of pro-angiogenic
IL-8 expression by HIF-1 and HIF-2 transcription factors
requires Nrf2 as well as c-Myc factors [203].
Not only pro-tumoral effects of HO-1 are described; due
to its antioxidant and genome protecting activities, HO-1
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may exert the protective effects against carcinogens and
may reduce the probability of tumor initiation (Fig. 10). In
agreement with that, we have observed that HO-1 may
protect healthy tissues against chemical induction of
squamous cell carcinoma, but in already growing tumors
HO-1 accelerates its progression toward more malignant
forms [204]. The dual role of HO-1 and its products,
mostly CO, in tumorigenesis depending on tumor type and
the balance between anti-angiogenic and proangiogenic
pathways activated in tumors by HO-1 was described in
several review papers including our recent review [70] and
summarized also in Fig. 10.
Nrf2 as a factor contributing to reductive stress
As mentioned above, Nrf2 is protective gene; however,
recent studies underline the fact that its constant overex-
pression might be detrimental. Wakabayashi et al. observed
that deletion of Keap1 leads to Nrf2 accumulation in
nucleus at constitutively high levels and the overproduction
of cytoprotective enzymes. Unexpectedly, Nrf2 accumu-
lation was not protective, but postnatal lethality was
observed as the result of Keap1 deletion [205]. Recent
studies focused at the understanding of this phenomenon,
and the involvement of Nrf2 in so-called reductive stress
was suggested. Reductive stress is induced by conditions
which promote the formation of excessive intracellular
NAD(P)H together with enormous activation of antioxidant
system and suppressed oxidative activity (reviewed in
[206]). The increased level of GSH, Nrf2 target gene,
might also act as a reducing equivalent, similar to
NAD(P)H. In fact, it was shown that the deleterious effects
of reductive stress were associated with dysregulation of
glutathione homeostasis (increased GSH level and ratio of
GSH/GSSG) and protein aggregation cardiomyopathy in
experimental mice model [207, 208]. Further experiments
identified Nrf2 as a factor contributing to reductive stress in
the human mutant protein aggregation cardiomyopathy
(MPAC) in mice [209]. Moreover, using MPAC transgenic
mice, Kannan et al. evidenced that attenuation of Nrf2
signaling prevents from reductive stress. Genetic deletion
of Nrf2 in such transgenic MPAC animals reduces aggre-
gation of toxic mutant proteins and prevents pathological
cardiac remodeling caused by reductive stress [210]. The
possible involvement and underlying mechanisms of Nrf2-
dependent reductive stress is summarized in recent review
by Narasimhan and Rajasekaran [206].
In summary, the maintaining Nrf2-Keap1 activity at
optimal levels to deal with both oxidative and reductive
stress and maintaining proper redox homeostasis is crucial
for the proper cell functioning.
Fig. 10 Role of Nrf2/HO-1 in tumor initiation and progression. Both
Nrf2 and HO-1 may decrease tumor initiation through the detoxifi-
cation and ROS scavenging mechanisms. On the other hand, this
cytoprotective system exerts stimulatory effect on the progression of
tumors mostly due to its anti-apoptotic, pro-angiogenic, pro-migratory
and modulatory influence on the expression of microRNAs. However,
in some tumors the opposite, inhibitory effect on progression of
tumors have been reported
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MicroRNAs and Nrf2/HO-1 system
As microRNAs are the master regulators of gene expression
and their level is frequently altered in age-related disorders
like cancer or neurodegenerative diseases, it could be easily
predicted that these small regulatory RNA molecules serve
important functions in modulating the Nrf2/HO-1 signaling
pathway (Fig. 11). However, the role of microRNAs in the
regulation of Nrf2 expression has been studied in limited
number of publications. Chorley et al. using ChIP-seq
analysis identified several microRNAs which may poten-
tially regulate Nrf2 activity [211]. The direct evidence of
Nrf2 regulation by the specific microRNAs has been shown
by Eades et al. who found that miR-200a that targets Keap1
is a regulator of Nrf2 activation in breast cancer cells [212].
On the other hand, miR-28 regulates Nrf2 in a Keap-1-
independent way by targeting the 30UTR of Nrf2 mRNA
and decreases Nrf2 expression in mammary epithelial cells
[213]. Another microRNA shown to inhibit Nrf2 mRNA
expression through direct effect on 30UTR in Nrf2 mRNA
was miR-144 [214].
Nrf2-dependent regulation of the microRNAs important
for some aspects of tumorigenesis has been identified. For
example, Nrf2 abrogates mir-1 and miR-206 and affects
lung carcinoma metabolism by reprogramming glucose
metabolism toward the pentose phosphate pathway (PPP)
and the tricarboxylic acid (TCA) cycle [215]. Similarly, we
showed the inhibitory effect of HO-1 on myomirs,
including miR-206 expression in C2C12 cells, and myo-
blast differentiation [216]. Moreover, we have also
demonstrated that HO-1 inhibits miR-378 and the interplay
between HO-1 and miR-378 significantly modulates
NSCLC progression and angiogenesis [217, 218]. Inter-
estingly, although HO-1 enhanced expression of
microRNAs processing enzymes (DGCR8, Drosha and
Dicer1) in NCI-H292 cell line and increased global
amounts of miRNA fraction [217], the expression of some
specific microRNAs was inhibited. For example, not only
miR-378, but also the expression of other pro-angiogenic
microRNAs, such as miR-17-92 and miR-210 were
downregulated. On the other hand, anti-angiogenic miR-
424 was upregulated by HO-1. Consistently tumors from
Fig. 11 miRNAs biogenesis and their role in the regulation of Nrf2
expression. microRNAs, transcribed by polymerase II as pri-miRNAs,
are cleaved by endoribonucleases Drosha and DGCR8, to be finally
exported from the nucleus by exportin-5. An endoribonuclease Dicer
processes the pre-miRNA, creating a mature, double-stranded miRNA
duplex. Endogenous miRNAs bind to target sequences in the 30UTR
regions of their target mRNA to produce translational arrest. Some
miRNAs, e.g., miR-200a can target Keap1 mRNA, leading to its
degradation and up-regulation of Nrf2 targets. On the other hand,
miR-144 can affect Nrf2 level in a Keap1-independent manner but
through direct targeting the 30UTR of Nrf2 mRNA causing the down-
regulation in Nrf2 expression
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HO-1 overexpressing NCI-H292 cells were less vascular-
ized and grew slower [217].
As mentioned above, Nrf2/HO-1 system plays a pivotal
role in neurodegenerative disorders, and a link with
microRNAs was found also in this subject. In primary
astrocytes overexpressing HO-1, the up-regulation of miR-
16, miR-17 and miR-140 with concomitant inhibition of
miR-29c, miR-138, miR-181a, miR-187, miR-206 and
miR-297 was observed [219]. The changes in the expres-
sion of those microRNAs and regulated mRNAs might be
responsible for the inflammatory, degenerative and apop-
tosis-triggered cell death.
All these results concerning the microRNAs regulation
further clarify molecular mechanisms by which Nrf2/HO-1
participate in pathogenesis and therapy of stress activated
and age-related diseases.
Conclusions
Nrf2/HO-1 pathways are widely studied in vertebrates. As
SKN-1 in C. elegans or CncC in D. melanogaster share
high homology with Nrf2, these organisms offer suit-
able models to study the function and biology of Nrf2
transcription factors. A large number of experiments indi-
cate the importance of Nrf2 and its equivalents in
embryonic development, stress signaling and aging.
Moreover, Nrf2-dependent genes, like HO-1 provide
cytoprotective effect and play a crucial role in the devel-
opment of oxidative and age-related disorders. The more
detailed analysis of microRNAs involvement in the regu-
lation of Nrf2/HO-1 may provide new ideas for the
treatment of abovementioned diseases. The involvement of
Nrf2 in the reductive stress in the mouse model of protein
aggregation cardiomyopathy suggests the contribution of
this transcriptional regulator of antioxidant genes in other
pathological situations related to unbalanced redox home-
ostasis. Although our knowledge about the role of Nrf2 in
controlling both physiology and disease progression
extended rapidly recently, thanks to model organisms
including flies and worms, still the influence of CNC fac-
tors on lifespan and health is an attractive scientific
problem to resolve.
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